Markets:

Overview

News

Currencies

International

Treasuries

Virios Therapeutics, Inc. - Common Stock (NQ:VIRI)

0.1550 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virios Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update

August 12, 2021

From Virios Therapeutics, Inc.

Via Business Wire

Earnings Scheduled For August 12, 2021 ↗

August 12, 2021

Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS...

Via Benzinga

Virios Therapeutics to Present at the SNN Network Summer Virtual Conference

August 11, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics Featured in Bloomberg TV Interview

August 09, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Thursday, August 12, 2021

August 05, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Why Virios Therapeutics' Stock Is Trading Higher Today ↗

May 18, 2021

Virios Therapeutics' (NASDAQ:VIRI) shares ar...

Via Benzinga

Virios Therapeutics Highlights Clinical Sites Fully Operational in Phase 2b Fibromyalgia Study Featuring FDA “Fast Track” Review Designated Antiviral Therapy, Oral IMC-1

July 26, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Fibromyalgia Treatment: 3 Pillars that Set Virios Therapeutics Apart from the Rest ↗

July 08, 2021

The success of any company most often begins with a solid foundation and strong pillars. These two are essential ingredients to the growth of a company. Weak foundations or...

Via Benzinga

Virios Therapeutics Stock Moves Higher On Promising IMC-1 Safety Data In Mid-Stage Fibromyalgia Trial ↗

June 09, 2021

Virios Therapeutics Inc (NASDAQ: VIRI) has announced that data from its Phase 2a PRID-201 trial demonstrated that IMC-1 was better tolerated than placebo in...

Via Benzinga

Virios Therapeutics Highlights Safety Data from Phase 2a Fibromyalgia Trial at the International Association for the Study of Pain (IASP) World Congress

June 09, 2021

From Virios Therapeutics, Inc.

Via Business Wire

62 Biggest Movers From Yesterday ↗

June 10, 2021

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID...

Via Benzinga

Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia

June 04, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

48 Stocks Moving In Wednesday's Mid-Day Session ↗

June 09, 2021

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An...

Via Benzinga

Virios Therapeutics Presents Phase 2a Fibromyalgia Trial Data on Efficacy Analyses of Key Secondary Endpoints at the EULAR European Congress of Rheumatology

June 02, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics Announces Oral Presentation of Clinical Data at Digestive Disease Week® (DDW)

May 24, 2021

From Virios Therapeutics, Inc.

Via Business Wire

58 Biggest Movers From Yesterday ↗

May 19, 2021

Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results. Ultralife Corporation (NASDAQ: ULBI)...

Via Benzinga

Virios Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update

May 13, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics to Present at the Benzinga Global Small Cap Conference

May 07, 2021

From Virios Therapeutics, Inc.

Via Business Wire

Virios Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on Thursday, May 13, 2021

May 06, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Earnings Scheduled For May 13, 2021 ↗

May 13, 2021

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...

Via Benzinga

Virios Therapeutics, Inc. Interview to Air on Bloomberg Television U.S. on the RedChip Money Report

April 16, 2021

From Virios Therapeutics, Inc. (VIRI)

Via Business Wire

Virios Therapeutics to Present at the Needham Virtual Healthcare Conference

April 07, 2021

From Virios Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.